Ventricular Tachycardia in Arrhythmogenic Right Ventricular Cardiomyopathies

Cardiac Electrophysiology: Fourth Edition

Volumn , Issue , 2004, Pages 588-600

  Fontaine, Guy ^a   Fornes, Paul ^b,c   Hebert, Jean Louis ^d,e   Prost Squarcioni, Catherine ^f   Jouven, Xavier ^c,g   Hulot, Jean Sébastien ^a   Frank, Robert ^a   Thomas, Daniel ^a,h  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Institut Cochin   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e BICÊTRE HOSPITAL   (France)

^f AVICENNE HOSPITAL   (France)

^g UNIVERSITÉ PARIS DESCARTES   (France)

^h SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33845491576     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B0-7216-0323-8/50066-X     Document Type: Chapter

References (70)

1. Fontaine G, Fontaliran F, Hebert JL, et al. Arrhythmogenic right ventricular dysplasia. Ann Rev Med 1999, 50:17-35.
2. Burke AP, Farb A, Tashko G, Virmani R Right ventricular cardiomyopathy and fatty infiltration of the right ventricular myocardium: Are they different diseases?. Circulation 1998, 97:1571-1580.
3. Richardson PJ, McKenna WJ, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology. Task Force on the Definition and Classification of Cardiomyopathies. Circulation 1996, 93:841-842.
4. Fontaine G, Fontaliran F, Frank R Arrhythmogenic right ventricular cardiomyopathies. Clinical forms and main differential diagnoses [editorial]. Circulation 1998, 97:1532-1535.
5. Fontaine G, Tonet J, Frank R Ventricular tachycardia in arrhythmogenic right ventricular dysplasia. Cardiac Electrophysiology: From Cell to Bedside 2000, 546-555. WB Saunders, Philadelphia. 3rd ed. D.P. Zipes, J. Jalife (Eds.).
6. Srivastra D, Thomas T, Lin Q, et al. Regulation of cardiac mesodermal and neural crest development by the bHLH transcription factor, dHAND. Nat Genet 1997, 16:154-160.
7. Pashmforoush M, Pomies P, Peterson KL, et al. Adult mice deficient in actinin-associated LIM-domain protein reveal a developmental pathway for right ventricular cardiomyopathy. Nat Med 2001, 7:591-597.
8. Fontaine G, Aouate P, Fontaliran F Repolarization and the genesis of cardiac arrhythmias. Role of body surface mapping [editorial]. Circulation 1997, 12:2600-2602.
9. Fornes P, Ratel S, Lecomte D Pathology of arrhythmogenic right ventricular cardiomyopathy/dysplasia. An autopsy study of 20 forensic cases. J Forens Sci 1998, 43:777-783.
10. Basso C, Thiene G, Corrado D, et al. Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy or myocarditis? Circulation 1996, 94:983-991.
11. Corrado D, Basso C, Thiene G, et al. Spectrum of clinico-pathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia. A multicenter study. J Am Coll Cardiol 1997, 30:1512-1520.
12. James TN, Nichols MM, Sapire DW, et al. Complete heart block and fatal right ventricular failure in an infant. Circulation 1996, 93:1588-1600.
13. McCrohon JA, John AS, Lorenz CH, et al. Left ventricular involvement in arrhythmogenic right ventricular cardiomyopathy. Circulation 2002, 105:1394.
14. Fontaine G, Fontaliran F, Rosas Andrade F, et al. The arrhythmogenic right ventricle. dysplasia versus cardiomyopathy. Heart Vessels 1995, 10:227-235.
15. Hoffman BF, Feinmark SJ, Guo SD Electrophysiologic effects of interactions between activated canine neutrophils and cardiac myocytes. J Cardiovasc Electrophysiol 1997, 8:679-687.
16. Fontaliran F, Fontaine G, Brestescher C, et al. Signification des infiltrats lymphoplasmocytaires dans la dysplasie ventriculaire droite arythmogene. Arch Mal Coeur 1995, 88:1021-1028.
17. Wesslen L, Pahlson C, Lindquist O, et al. An increase in sudden unexpected cardiac deaths among young Swedish orienteers during 1979-1992. Eur Heart J 1996, 17:902-910.
18. Maron BJ, Shirani J, Poliac LC, et al. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA 1996, 276:199-204.
19. Nemec J, Edwards BS, Osborn MJ, Edwards WD Arrhythmogenic right ventricular dysplasia masquerading as dilated cardiomyopathy. Am J Cardiol 1999, 84:237-239.
20. Girard F, Fontaine G, Fontaliran F, et al. Catastrophic global heart failure in a case of non arrhythmogenic right ventricular dysplasia. Heart Vessels 1997, 12:152-154.
21. Hayashi H, Fujiki A, Tani M, et al. Role of sympathovagal balance in the initiation of idiopathic ventricular tachycardia originating from right ventricular outflow tract. Pacing Clin Electrophysiol 1997, 20:2371-2377.
22. Marchlinski FE, Deely MP, Zado ES Sex-specific triggers for right ventricular outflow tract tachycardia. Am Heart J 2000, 139:1009-1013.
23. Jadonath RL, Schwartzman DS, Preminger MW, et al. Utility of the 12-lead electrocardiogram in localizing the origin of right ventricular outflow tract tachycardia. Am Heart J 1995, 130:1107-1113.
24. Yoshida Y, Hirai M, Murakami Y, et al. Localization of precise origin of idiopathic ventricular tachycardia from the right ventricular outflow tract by a 12-lead ECG: A study of pace mapping using a multielectrode "basket" catheter. Pacing Clin Electrophysiol 1999, 22:1760-1768.
25. Krebs ME, Krause PC, Engelstein ED, et al. Ventricular tachycardias mimicking those arising from the right ventricular outflow tract. J Cardiovasc Electrophysiol 2000, 11:45-51.
26. o'Connor BK, Case CL, Sokoloski MC, et al. Radiofrequency catheter ablation of right ventricular outflow tachycardia in children and adolescents. J Am Coll Cardiol 1996, 27:869-874.
27. Aiba T, Shimizu W, Taguchi A, et al. Clinical usefulness of a multielectrode basket catheter for idiopathic ventricular tachycardia originating from right ventricular outflow tract. J Cardiovasc Electrophysiology 2001, 12:511-517.
28. Friedman PA, Asirvatham SJ, Grice S, et al. Noncontact mapping to guide ablation of right ventricular outflow tract tachycardia. J Am Coll Cardiol 2002, 39:1808-1812.
29. Chinushi M, Aizawa Y, Takahashi K, et al. Morphological variation of nonreentrant idiopathic ventricular tachycardia originating from the right ventricular outflow tract and effect of radiofrequency lesion. Pacing Clin Electrophysiol 1997, 20:325-336.
30. Pinamonti B, Miani D, Sinagra G, et al. Familial right ventricular dysplasia with biventricular involvement and inflammatory infiltration. Heart 1996, 76:66-69.
31. Rampazzo A, Nava A, Malacrida S, et al. Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet 2002, 71:1200-1206.
32. Carvajal-Huerta L Epidermolytic palmoplantar keratoderma with woolly hair and dilated cardiomyopathy. J Am Acad Dermatol 1998, 39:418-421.
33. Tiso N, Stephan DA, Nava A, et al. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet 2001, 10:189-194.
34. Bauce B, Nava A, Rampazzo A, et al. Familial effort polymorphic ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy map to chromosome 1q42-43. Am J Cardiol 2000, 85:573-579.
35. Bauce B, Rampazzo A, Basso C, et al. Screening of ryanodine receptor type 2 mutations in families with effort-induced polymorphic ventricular arrhythmias and sudden death: Early diagnosis of asymptomatic carriers. J Am Coll Cardiol 2002, 40:341-349.
36. Swan H, Piippo K, Viitasalo MT, et al. Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts. J Am Coll Cardiol 1999, 34:2035-2042.
37. Leenhardt A, Lucet V, Denjoy I, et al. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation 1995, 91:1512-1519.
38. Kaplan SR, Protonotarios N, Tsatsopoulou A, et al. Diminished myocardial connexin43 expression and gap junction remodeling in naxos disease [abstract]. Pacing Clin Electrophysiol 2002, 24(pt II):525.
39. Protonotarios N, Tsatsopoulou A, Anastasakis A, et al. Genotype-phenotype assessment in autosomal recessive arrhythmogenic right ventricular cardiomyopathy (Naxos disease) caused by a deletion in plakoglobin. J Am Coll Cardiol 2001, 38:1477-1484.
40. Corrado D, Basso C, Angelini A, Thiene G Sudden death in young people with apparently isolated mitral valve prolapse [abstract]. Pacing Clin Electrophysiol 1997, 20(pt II):1120.
41. Fontaine G, Fornes P, Mallat Z, et al. Why patients with arrhythmogenic right ventricular dysplasia die suddenly?. Fighting Sudden Cardiac Death: A Worldwide Challenge 2000, 251-263. NY, Futura, Armonk. E. Aliot, J. Clementy, E.N. Prystowsky (Eds.).
42. Matsuo K, Akahoshi M, Nakashima E, et al. The prevalence, incidence and prognostic value of the Brugada-type electrocardiogram: A population-based study of four decades. J Am Coll Cardiol 2001, 38:765-770.
43. Furuhashi M, Uno K, Tsuchihashi K, et al. Prevalence of asymptomatic ST segment elevation in right precordial leads with right bundle branch block (Brugada-type ST shift) among the general Japanese population. Heart 2001, 86:161-166.
44. Vatta M, Dumaine R, Varghese G, et al. Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome. Hum Mol Genet 2002, 11:337-345.
45. Shimizu W, Aiba T, Kurita T, Kamakura S Paradoxic abbreviation of repolarization in epicardium of the right ventricular outflow tract during augmentation of Brugada-type ST segment elevation. J Cardiovasc Electrophysiol 2001, 12:1418-1421.
46. Brugada J, Brugada P, Brugada R The syndrome of right bundle branch block ST segment elevation in V1 to V3 and sudden death. The Brugada syndrome. Europace 1999, 1:156-166.
47. Saura D, Garcia-Alberola A, Carrillo P, et al. Brugada-like electrocardiographic pattern induced by fever. Pacing Clin Electrophysiol 2002, 25:856-859.
48. Morita H, Nagase S, Kusano KF, Ohe T Spontaneous T wave alternans and premature ventricular contractions during febrile illness in a patient with Brugada syndrome. J Cardiovasc Electrophysiol 2002, 13:816-818.
49. Dumaine R, Towbin JA, Brugada P, et al. Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent. Circ Res 1999, 85:803-809.
50. Brugada R Use of intravenous antiarrhythmics to identify concealed Brugada syndrome. Curr Control Trials Cardiovasc Med 2000, 1:45-47.
51. Miyazaki T, Mitamura H, Miyoshi S, et al. Autonomic and antiarrhythmic drug modulation of ST segment in patients with Brugada syndrome. J Am Coll Cardiol 1996, 27:1061-1070.
52. Brugada P, Geelen P, Brugada R, et al. Prognostic value of electrophysiologic investigations in Brugada syndrome. J Cardiovasc Electrophysiology 2001, 12:1004-1007.
53. Eckardt L, Kirchhof P, Schulze-Bahr E, et al. Electrophysiologic investigation in Brugada syndrome. Yield of programmed ventricular stimulation at two ventricular sites with up to three premature beats. Eur Heart J 2002, 23:1394-1401.
54. Gasparini G, Priori SG, Mantica M, et al. Programmed electrical stimulation in Brugada syndrome: How reproducible are the results?. J Cardiovasc Electrophysiology 2002, 13:880-887.
55. Tanaka H, Kinoshita O, Uchikawa S, et al. Successful prevention of recurrent ventricular fibrillation by intravenous isoproterenol in a patient with Brugada syndrome. Pacing Clin Electrophysiol 2001, 24:1293-1294.
56. Masaki R, Watanabe I, Nakai T, et al. Role of signal-averaged electrocardiograms for predicting the inducibility of ventricular fibrillation in the syndrome consisting of right bundle branch block and ST segment elevation in leads V1-V3. Jpn Heart J 2002, 23:367-378.
57. Wichter T, Matheja P, Eckardt L, et al. Cardiac autonomic dysfunction in Brugada syndrome. Circulation 2002, 106:e59-e60.
58. Eckardt L, Bruns HJ, Paul MH, et al. Body surface area of ST elevation and the presence of late potentials correlate to the inducibility of ventricular tachyarrhythmias in Brugada syndrome. J Cardiovasc Electrophysiol 2002, 13:742-749.
59. Nanke T, Nakazawa K, Arai M, et al. Clinical significance of the dispersion of the activation-recovery interval and recovery time as markers for ventricular fibrillation susceptibility in patients with Brugada syndrome. Circ J 2002, 66:549-552.
60. Kanda M, Shimizu W, Matsuo K, et al. Electrophysiologic characteristics and implications of induced ventricular fibrillation in symptomatic patients with Brugada syndrome. J Am Coll Cardiol 2002, 39:1799-1805.
61. Kurita T, Shimizu W, Inagaki M, et al. The electrophysiologic mechanism of ST-segment elevation in Brugada syndrome. J Am Coll Cardiol 2002, 40:330-334.
62. Itoh H, Shimizu M, Ino H, et al. Arrhythmias in patients with Brugada-type electrocardiographic findings. Jpn Circ J 2001, 65:483-486.
63. Morita H, Kusano-Fukushima K, Nagase S, et al. Atrial fibrillation and atrial vulnerability in patients with Brugada syndrome. J Am Coll Cardiol 2002, 40:1427-1444.
64. Corrado D, Nava A, Buja G, et al. Familial cardiomyopathy underlies syndrome of right bundle branch block, ST segment elevation and sudden death. J Am Coll Cardiol 1996, 27:443-448.
65. Corrado D, Basso C, Buja G, et al. Right bundle branch block, right precordial ST-segment elevation, and sudden death in young people. Circulation 2001, 103:710-717.
66. Priori SG, Napolitano C, Gasparini G, et al. Natural history of Brugada syndrome: Insights for risk stratification and management. Circulation 2002, 105:1342-1347.
67. Brugada J, Brugada R, Antzelevitch C, et al. Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordials leads V1 to V3. Circulation 2002, 105:73-78.
68. Ayerza MR, de Zutter M, Goethals M, et al. Heart transplantation as last resort against Brugada syndrome. J Cardiovasc Electrophysiol 2002, 13:943-944.
69. Link MS, Wang PJ, Haugh CJ, et al. Arrhythmogenic right ventricular dysplasia: Clinical results with implantable cardioverter defibrillators. J Interv Card Electrophysiol 1997, 1:41-48.
70. Fontaine G, Tonet J, Gallais Y, et al. Ventricular tachycardia catheter ablation in arrhythmogenic right ventricular dysplasia. A 16 year experience. Curr Cardiol Rep 2000, 2:498-506.